Exact Sciences (EXAS) Cologuard Patient Population Expands ~25% - SVB Leerink
Tweet Send to a Friend
SVB Leerink analyst Puneet Souda reiterated an Outperform rating on Exact Sciences (NASDAQ: EXAS) after the company announced a label ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


